| Year |
Citation |
Score |
| 2023 |
Ostojić M, Jevrić M, Mitrović-Ajtić O, Živić K, Tanić M, Čavić M, Srdić-Rajić T, Grahovac J. Nischarin expression may have differing roles in male and female melanoma patients. Journal of Molecular Medicine (Berlin, Germany). 101: 1001-1014. PMID 37382661 DOI: 10.1007/s00109-023-02339-y |
0.333 |
|
| 2020 |
Erin N, Grahovac J, Brozovic A, Efferth T. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 53: 100715. PMID 32679188 DOI: 10.1016/J.Drup.2020.100715 |
0.46 |
|
| 2019 |
Grahovac J, Srdić-Rajić T, Francisco Santibañez J, Pavlović M, Čavić M, Radulović S. Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib by altering cell bioenergetics. Cancer Biology & Medicine. 16: 247-263. PMID 31516746 DOI: 10.20892/J.Issn.2095-3941.2018.0375 |
0.41 |
|
| 2019 |
Grahovac J, Han S, Liu H, Duquette M, Luengo A, Schanne D, Liss AS, Heiden MGV, Jain RK, Boucher Y. Abstract B06: The angiotensin receptor blocker and partial PPARγ agonist telmisartan inhibits the growth of pancreatic ductal adenocarcinoma Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B06 |
0.465 |
|
| 2019 |
Liu H, Ho WW, Naxerova K, Grahovac J, Nia H, Chen I, Posada JM, Schanne DH, Pinter M, Crain J, Qi X, Clark JW, Hong TS, Ryan DP, Huang P, et al. Abstract A18: Angiotensin receptor blockers normalize the pancreatic ductal adenocarcinoma stroma by reprogramming carcinoma-associated fibroblasts Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A18 |
0.428 |
|
| 2018 |
Daubriac J, Han S, Grahovac J, Smith E, Hosein A, Buchanan M, Basik M, Boucher Y. The crosstalk between breast carcinoma-associated fibroblasts and cancer cells promotes RhoA-dependent invasionIGF-1 and PAI-1. Oncotarget. 9: 10375-10387. PMID 29535813 DOI: 10.18632/Oncotarget.23735 |
0.502 |
|
| 2017 |
Bazou D, Maimon N, Gruionu G, Grahovac J, Seano G, Liu H, Evans CL, Munn LL. Vascular beds maintain pancreatic tumor explants for ex vivo drug screening. Journal of Tissue Engineering and Regenerative Medicine. PMID 28568605 DOI: 10.1002/Term.2481 |
0.373 |
|
| 2016 |
Incio J, Liu H, Suboj P, Chin SM, Chen IX, Pinter M, Ng MR, Nia HT, Grahovac J, Kao S, Babykutty S, Huang Y, Jung K, Rahbari NN, Han X, et al. Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy. Cancer Discovery. PMID 27246539 DOI: 10.1158/2159-8290.Cd-15-1177 |
0.334 |
|
| 2016 |
Grahovac J, Han S, Liu H, Jain R, Boucher Y. Abstract B41: The angiotensin receptor blocker telmisartan inhibits the growth of pancreatic ductal adenocarcinoma and improves survival Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-B41 |
0.423 |
|
| 2016 |
Incio J, Liu H, Suboj P, Min S, Chen I, Ng M, Nia H, Grahovac J, Kao S, Babykutty S, Huang Y, Jung K, Rahbari N, Han X, Chauhan V, et al. Abstract 898: Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy Cancer Research. 76: 898-898. DOI: 10.1158/1538-7445.Am2016-898 |
0.369 |
|
| 2015 |
Han S, Grahovac J, Vardam T, Boucher Y. Abstract B70: Combination of AT1R blockade with CD40 activation provides enhanced therapeutic efficacy for mouse pancreatic adenocarcinoma Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-B70 |
0.378 |
|
| 2014 |
Schwabl P, Payer BA, Grahovac J, Klein S, Horvatits T, Mitterhauser M, Stift J, Boucher Y, Trebicka J, Trauner M, Angermayr B, Fuhrmann V, Reiberger T, Peck-Radosavljevic M. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats. Journal of Hepatology. 60: 1135-42. PMID 24530596 DOI: 10.1016/J.Jhep.2014.01.025 |
0.316 |
|
| 2014 |
Grahovac J, Wells A. Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion. Laboratory Investigation; a Journal of Technical Methods and Pathology. 94: 31-40. PMID 24247562 DOI: 10.1038/Labinvest.2013.132 |
0.566 |
|
| 2013 |
Wells A, Grahovac J, Wheeler S, Ma B, Lauffenburger D. Targeting tumor cell motility as a strategy against invasion and metastasis. Trends in Pharmacological Sciences. 34: 283-9. PMID 23571046 DOI: 10.1016/J.Tips.2013.03.001 |
0.602 |
|
| 2013 |
Grahovac J, Becker D, Wells A. Melanoma cell invasiveness is promoted at least in part by the epidermal growth factor-like repeats of tenascin-C. The Journal of Investigative Dermatology. 133: 210-20. PMID 22951722 DOI: 10.1038/Jid.2012.263 |
0.595 |
|
| 2012 |
Grahovac J, Wells A. Abstract 485: Epidermal growth factor-like repeats of Tenascin C promote melanoma cell invasion, possibly by enabling mesenchymal to ameboid migration transition Cancer Research. 72: 485-485. DOI: 10.1158/1538-7445.Am2012-485 |
0.626 |
|
| 2011 |
Wells A, Chao YL, Grahovac J, Wu Q, Lauffenburger DA. Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Frontiers in Bioscience (Landmark Edition). 16: 815-37. PMID 21196205 DOI: 10.2741/3722 |
0.629 |
|
| 2011 |
Grahovac J, Wells A. Abstract 421: Epidermal growth factor-like repeats of tenascin C alter melanoma cell migration both directly and through alteration of the ECM Cancer Research. 71: 421-421. DOI: 10.1158/1538-7445.Am2011-421 |
0.615 |
|
| 2010 |
Hood BL, Grahovac J, Flint MS, Sun M, Charro N, Becker D, Wells A, Conrads TP. Proteomic analysis of laser microdissected melanoma cells from skin organ cultures. Journal of Proteome Research. 9: 3656-63. PMID 20459140 DOI: 10.1021/Pr100164X |
0.538 |
|
| Show low-probability matches. |